Follow
Ysebaert Loic
Ysebaert Loic
Hematologist
Verified email at iuct-oncopole.fr
Title
Cited by
Cited by
Year
Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study
A Jaccard, N Gachard, B Marin, S Rogez, M Audrain, F Suarez, H Tilly, ...
Blood, The Journal of the American Society of Hematology 117 (6), 1834-1839, 2011
4102011
Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): a randomised phase 3 trial
R Delarue, H Tilly, N Mounier, T Petrella, G Salles, C Thieblemont, ...
The lancet oncology 14 (6), 525-533, 2013
3632013
Rituximab plus lenalidomide in advanced untreated follicular lymphoma
F Morschhauser, NH Fowler, P Feugier, R Bouabdallah, H Tilly, ...
New England Journal of Medicine 379 (10), 934-947, 2018
3412018
The germinal center/activated B-cell subclassification has a prognostic impact for response to salvage therapy in relapsed/refractory diffuse large B-cell lymphoma: a bio-CORAL …
C Thieblemont, J Briere, N Mounier, HU Voelker, W Cuccuini, E Hirchaud, ...
J Clin Oncol 29 (31), 4079-4087, 2011
3362011
Ibrutinib treatment affects collagen and von Willebrand factor-dependent platelet functions
M Levade, E David, C Garcia, PA Laurent, S Cadot, AS Michallet, ...
Blood, The Journal of the American Society of Hematology 124 (26), 3991-3995, 2014
3202014
Predictive factors of early progression after CAR T-cell therapy in relapsed/refractory diffuse large B-cell lymphoma
L Vercellino, R Di Blasi, S Kanoun, B Tessoulin, C Rossi, M D'Aveni-Piney, ...
Blood advances 4 (22), 5607-5615, 2020
2702020
Early-onset invasive aspergillosis and other fungal infections in patients treated with ibrutinib
D Ghez, A Calleja, C Protin, M Baron, MP Ledoux, G Damaj, M Dupont, ...
Blood, The Journal of the American Society of Hematology 131 (17), 1955-1959, 2018
2522018
Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation
S Kamel, L Horton, L Ysebaert, M Levade, K Burbury, S Tan, ...
Leukemia 29 (4), 783-787, 2015
2502015
Efficacy and tolerability of nivolumab after allogeneic transplantation for relapsed Hodgkin lymphoma
C Herbaux, J Gauthier, P Brice, E Drumez, L Ysebaert, H Doyen, ...
Blood, The Journal of the American Society of Hematology 129 (18), 2471-2478, 2017
2442017
Expression of β-catenin by acute myeloid leukemia cells predicts enhanced clonogenic capacities and poor prognosis
L Ysebaert, G Chicanne, C Demur, F De Toni, N Prade-Houdellier, ...
Leukemia 20 (7), 1211-1216, 2006
2382006
Sustained progression-free survival benefit of rituximab maintenance in patients with follicular lymphoma: long-term results of the PRIMA study
E Bachy, JF Seymour, P Feugier, F Offner, A López-Guillermo, D Belada, ...
Journal of Clinical Oncology 37 (31), 2815, 2019
2202019
Efficacy and safety of idelalisib in combination with ofatumumab for previously treated chronic lymphocytic leukaemia: an open-label, randomised phase 3 trial
JA Jones, T Robak, JR Brown, FT Awan, X Badoux, S Coutre, ...
The Lancet Haematology 4 (3), e114-e126, 2017
2112017
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
JJ Fournié, H Sicard, M Poupot, C Bezombes, A Blanc, F Romagné, ...
Cellular & molecular immunology 10 (1), 35-41, 2013
2012013
Bromohydrin pyrophosphate enhances antibody-dependent cell-mediated cytotoxicity induced by therapeutic antibodies
J Gertner-Dardenne, C Bonnafous, C Bezombes, AH Capietto, ...
Blood, The Journal of the American Society of Hematology 113 (20), 4875-4884, 2009
1922009
Anaplastic lymphoma kinase-positive diffuse large B-cell lymphoma: a rare clinicopathologic entity with poor prognosis
C Laurent, C Do, RD Gascoyne, L Lamant, L Ysebaert, G Laurent, ...
J clin oncol 27 (25), 4211-4216, 2009
1902009
Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis
C Recher, L Ysebaert, O Beyne-Rauzy, V Mansat-De Mas, JB Ruidavets, ...
Cancer research 64 (9), 3191-3197, 2004
1892004
MYC + diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation
W Cuccuini, J Briere, N Mounier, HU Voelker, A Rosenwald, C Sundstrom, ...
Blood, The Journal of the American Society of Hematology 119 (20), 4619-4624, 2012
1862012
A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia
F De Toni, C Racaud-Sultan, G Chicanne, V Mas, C Cariven, F Mesange, ...
Oncogene 25 (22), 3113-3122, 2006
1722006
Single-cell RNA sequencing unveils the shared and the distinct cytotoxic hallmarks of human TCRVδ1 and TCRVδ2 γδ T lymphocytes
G Pizzolato, H Kaminski, M Tosolini, DM Franchini, F Pont, F Martins, ...
Proceedings of the National Academy of Sciences 116 (24), 11906-11915, 2019
1662019
Atrial fibrillation in CLL patients treated with ibrutinib. An international retrospective study
PA Thompson, V Lévy, CS Tam, C Al Nawakil, FX Goudot, A Quinquenel, ...
British journal of haematology 175 (3), 462-466, 2016
1392016
The system can't perform the operation now. Try again later.
Articles 1–20